Author:
Mulenga Veronica,Musiime Victor,Kekitiinwa Adeodata,Cook Adrian D,Abongomera George,Kenny Julia,Chabala Chisala,Mirembe Grace,Asiimwe Alice,Owen-Powell Ellen,Burger David,McIlleron Helen,Klein Nigel,Chintu Chifumbe,Thomason Margaret J,Kityo Cissy,Walker A Sarah,Gibb Diana M
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Paediatric abacavir–lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial;The Lancet HIV;2024-02
2. Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1–2 dose-confirmation study;The Lancet HIV;2023-08
3. Safety and efficacy of abacavir for treating infants, children, and adolescents living with HIV: a systematic review and meta-analysis;The Lancet Child & Adolescent Health;2022-10
4. Safety of Antiretroviral Therapy in the Treatment of HIV/AIDS in Children: Systematic Review and Meta-analysis;Aids Reviews;2022-01-11
5. Abacavir pharmacokinetics in African children living with HIV: A pooled analysis describing the effects of age, malnutrition and common concomitant medications;British Journal of Clinical Pharmacology;2021-08-12